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A B S T R A C T
Depression is one of the most common complications in patients with chronic somatic illnesses. Comorbidity of de-
pression with physical illness often remains unrecognized and untreated, additionally aggravating the somatic illness
itself, its treatment and prognosis. The aim of this study was to investigate the prevalence of depression in chronic so-
matic patients suffering from diabetes, epilepsy, asthma, chronic obstructive pulmonary disease (COPD) and hypothyroi-
dism. Patients, who were regularly attending control examinations in neurological and internal medicine out-patient de-
partments, were tested for the presence of depression with Beck Depression Inventory. The sample comprised 2153
chronic somatic patients aged between 18 and 80 years. Out of this total, 228 patients (10.6%) did not complete the study,
(5.12%) refused to participate, and (5.5%) of the patients were technical failures. 1925 patients completed the study, and
1383 of them were not depressive. In 542 patients (28.5%) depression was confirmed, being almost twice more frequent in
women, 346 (64%) vs. 196 (36%) male. Among these depressed examinees, mild depression was found in 284 (52.4%),
major in 186 (34.3%) and severe in 72 (13.3%) chronic somatic patients. The majority of patients were aged over 55 yrs
(49%). This population contained the largest number of depressed examinees (49.9%). The prevalence of depression with
regard to subgroups shows that (25.6%) of asthma patients were depressed, as well as (26.6%) of those with COPD. These
two groups did not present statistically significant differences regarding gender. The depression level of (32.2%) was
found in patients with diabetes, of (29.6%) in patients with epilepsy and of (24.2%) among those with hypothyroidism. As
for gender, statistically significant difference was found in the last three groups of patients (p<0.001).
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Introduction
Depression is a serious and frequent disorder, influ-
encing the whole life of a patient1. Out of fear and nu-
merous stigmatizing attitudes, depressed patients hardly
accept or even deny the fact that they are actually ill1,2.
Due to ignorance and numerous somatic symptoms ac-
companied by anergy and fatigue, the suffering people
and their relatives and friends often do not recognize
depression1. The doctors often fail to observe it as well.
Because of theoretical and practice biases, there is a
strong tendency for a medical practitioner to focus on so-
matic rather than on emotional aspects of functioning
and disease3. Symptoms of depression as fatigue and
lethargy can aggravate the energy loss in many chronic
conditions, thus being one of the most common complica-
tions of a chronic illness3,4. Depression and illness may
often occur together, because physical changes associated
with the illness can trigger depressive mood1,3. The oc-
currence risk for depression is generally (10–22%) for
women and (5–12%) for men1,4. However, those with
chronic illnesses face a much higher risk4. This fact is an
important public health issue, because depressive disor-
ders generally have been associated with the outcomes of
chronic diseases and have contributed to the high health
care costs5. The risk of suicide has been estimated to be
10 times higher than in general population6. The lifetime
risk of developing a depressive episode now approaches
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(15%)1,5. World Health Organization ranks depression as
the world’s fourth greatest public health problem7. This
situation is growing even more problematic, because the
age of onset of the first depressive episode is becoming
progressively younger, causing greater risks of recur-
rence and chronicity4. WHO estimates that in the year
2020, depression would be the second leading cause of
morbidity in the world7. Women have about two times
greater lifetime risk of developing a major depressive
episode7,8. The co-morbidity of mental and physical ill-
ness is currently of considerable interest. It is generally
accepted that a somatic illness creates an increased risk
of psychiatric impairment4,9. The physical illness itself is
often considered a reason enough to be depressed1,9.
Symptoms of depression like lowmood, fatigue, insomnia
and loss of interest may exacerbate symptoms of chronic
somatic illnesses4,10. Having in mind the cited facts, the
goal of the study was to investigate and to point to a large
number of unrecognized and untreated depressions in
patients with somatic illnesses, in order to additionally
sensitize physicians in somatic medicine (internists, neu-
rologists) and psychiatrists for the mentioned problem.
According to literature survey (1970–2004), no clinical
trials in Croatia have so far compared chronic somatic ill-
nesses and the prevalence of depression. The prevalence
of co-morbid depression with type 1 or type 2 diabetes
was found to be (30%) in uncontrolled, (32%) in clinical
and over (21%) in controlled studies11,12. In epilepsy, the
prevalence of depression is higher than in a matched pop-
ulation, ranging from (20%) to (55%) in patients with re-
current seizures and (20%) to (30%) in patients with con-
trolled epilepsy13,14. Asthma has historically been consi-
dered a psychosomatic disease where emotional stress
exacerbates symptoms15. Several studies have shown high
rates of mood disorders with the prevalence ranging
from (14%) to (25%)15,20. Patients with COPD have been
characterized as a population of chronically ill patients
with a higher than normal prevalence of psychiatric dis-
orders, depression being found in (19–26%)16. Patients
with hypothyroidism have also a higher prevalence of de-
pressive disorders than the general population, (15–25%)17.
Material and Methods
The level of depressiveness was examined in chronic
patients who regularly come to medical examination in
neurological and internal medicine out-patient depart-
ments. It was measured by the self-report Beck Depres-
sion Inventory (BDI). The patients were asked to com-
plete BDI while waiting for their routine out-patient
appointment. The BDI is an effective screening test for
depression in chronic somatic patients, verified in a sig-
nificant number of published studies18,19. The partici-
pants, depending on the obtained BDI scale points, were
separated into those who, according to their answers,
were not depressive, or had mild, major and severe de-
pression respectively. The examinees with the positive
score for depression were referred to an obligatory psy-
chiatric examination. The presence and level of depres-
sion was confirmed during a psychiatric screening ac-
cording to the ICD-10, Classification of mental and be-
havioral disorders, 10revision10. The investigation en-
rolled patients suffering from diabetes, epilepsy, asthma,
chronic obstructive pulmonary disease (COPD) and hy-
pothyroidism. The initial sample consisted of 2153
chronic somatic patients aged between 18 and 80 years,
who voluntarily accepted to participate in the research
and signed an informed consent approved by the Ethical
Committee. Examinees were first divided according to
gender, and then into three age groups: 18–35 yrs, 36–55
yrs, and over 55 years. The next division into five sub-
groups was done according to their diagnoses. Included
patients were stable, took prescribed medication and
came to control examinations in regular time spans.
They were under continual treatment due to somatic dis-
ease for more than a year. The total of 2153 patients with
chronic somatic illnesses underwent statistical analysis.
Out of this total, 228 (10.6%) patients did not complete
the study, because 110 (5.1%) refused to participate, and
118 (5.5%) patients were already treated for depression,
or did not correctly fill in the questionnaire, or dropped
out due to some other technical reason. The patients
with a high degree of depression established on the basis
of BDI scale and psychiatric opinion, with or without sui-
cidal thoughts, were referred to hospital psychiatric
treatment. The significance of differences in qualitative
measures levels was tested by the c2-test.
Results and Discussion
The study was successfully completed by 1925 pa-
tients, while 1383 of them did not fulfill the criteria for a
depressive disorder. The depressive disorder was found
in 542 of them (28.2%), mild in 284 (52.4%), major in 186
(34.3%) and severe in 72 (13.3%). The results are pre-
sented in (Figure 1). The results related to gender sho-
wed depression in 346 women, mild in 179 (52%), major
in 122 (35%), severe in 45 (13%), and in 196 male exa-
minees, mild in 107 (55%), major in 64 (33%), severe in
25 (12%). The results are presented in (Figures 2a and
2b). The prevalence of depression was also calculated in
five subgroups according to their chronic somatic dis-
ease. The number and degree of depression in regard to
age and gender were analyzed in 356 examinees with
asthma, 301 with COPD, 510 with epilepsy, 456 with dia-
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Fig. 1. Prevalence of depression in 1925 patients with
chronic somatic illness.
betes and 302 examinees with hypothyroidism. The re-
sults are presented in (Figure 3) and (Figure 4). Out of
356 tested asthma patients, depressive disorder was
found in 91 (25.6%), 52 female and 39 male. Statistically
significant difference was not found in relation to gender.
Mild depression was found in 52 (57%), major in 27 (30%)
and severe in 12 (13%) patients. Among 301 patients
with COPD, depressive disorder was registered in 80
(26.6%), 44 female, 36 male. As for gender, statistically
significant difference was not observed either. Mild de-
pression was found in 42 (52.5%), major in 28 (35%) and
severe in 10 (12.5%) patients. Among 510 patients with
epilepsy, depressive disorder was revealed in 151 (29.6%),
99 female and 52 male patients. The statistically signifi-
cant difference (p<0.001) related to gender was found
here. Mild depression was established in 79 (52%), major
in 52 (35%) and severe in 20 (13%) patients. Depressive
disorder was present in 147 (32.2%), 99 female and 48
male diabetic patients. In depressed diabetic patients,
statistically significant difference (p<0.001) was also ob-
served in connection to gender. Mild depression was
found in 73 (50%), major in 54 (37%) and severe in 20
(13%) of them. Among 302 patients with hypothyroi-
dism, depressive disorder was found in 73 (24.2%), 52 fe-
male and 21 male. Statistically significant difference
(p<0.001) was again connected with gender. Mild depres-
sion was found in 38 (55%) patients, major in 25 (34%)
and severe in 10 (11%). Regarding age, the examinees
were divided into three groups: the first up to the age of
30, 325 (15%), the second aged 31 – 55 yrs, 756 (36%),
and the third group over 55 years, 1072 (49%) examinees.
Out of 542 depressed chronic somatic patients in the first
group, aged up to 30 years, 78 (14%) depressives were
found, in the second, aged 31–55 years, 194 (36%), and in
the third aged over 55, 270 (49.9%). The study results
show that the average prevalence of depression in the
five groups of chronic medical patients was (28.2%). Ac-
cording to depression prevalence data in literature, they
had a 2.5 times greater risk for depression than general
population1,4. The obtained results connected with gen-
der revealed 346 female and 196 male depressed pa-
tients. This finding confirms the results from the litera-
ture, which stress that women having chronic somatic
illnesses are 2 to 3 times more depressive than men1,7–10.
The division according to the degree of depression also
confirms some of the already known results. They
showed the occurrence of major depression of about
(30%)7,10. Our investigation gave the result of (34.3%),
without significant differences regarding gender. Inter-
esting is the number of 72 (13.3%) severely depressed
examinees, to whom an obligatory psychiatric consulta-
tion and hospital treatment were recommended. The re-
sults connected with age point that the majority of
examinees were over 55 years of age. This population
presented the largest number of depressive examinees
(49.9%). The examinees aged 36–55 were depressive in
(36%), while the number of depressives with chronic so-
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Fig. 3. Percentage of depressive chronic somatic patients divided
according to chronic illnesses.
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Fig. 4. Number of chronic somatic patients regarding depression
and gender.
matic diseases was 78 (14.1%). This finding confirms the
literature data1,4. The results of depression prevalence
show that (25.6%) of the patients treated for asthma
were depressive. Statistically significant differences re-
garding age were not found in this group, but in it prevail
examinees under 35, and those aged 36–55 yrs. In com-
parison with several similar studies, the prevalence of
mood disorders ranges from (14–25%)20. The presence of
asthma has been associated with increased anxiety and
depression, both being found among patients with an
acute life-threatening asthma attacks20,21. Depression
can also contribute to asthma attacks by hampering the
immune system21. Patients with COPD have been char-
acterized as a population of chronically ill patients with a
higher than average prevalence of psychiatric disorders
like depression22,23. In studies published in various jour-
nals a relatively high prevalence of depression (19–26%)
was found both in patients and controls23. The results in
our study show depression in (26.6%) examinees with
COPD, the majority of these patients are over 55 years of
age (89%). According to literature, the prevalence of
co-morbid depression in type 1 or type 2 diabetes was
found to be (30%) in uncontrolled and over (21%) in con-
trolled studies, while (31%) were assessed by self-report
questionnaires12,24. The rate of co-morbid depression is
significantly higher in diabetic women (28%) than in
men (18%)24. Our study revealed a high rate of depres-
sion in diabetic patients (32.2%). Statistically significant
difference was found in relation to gender (p<0.001).
The same statistically significant differences (p<0.001)
regarding gender were also found in the groups of exa-
minees with epilepsy and hypothyroidism, with 2 to 2.5
times greater number of female depressives. Depression
was found in (29.6%) of the epileptic examinees, and
(35%) of them presented major depression. The litera-
ture data point that the prevalence of depression in epi-
lepsy is higher than in a matched population of healthy
control subjects9,25. It ranges from (20%) to (55%) in pa-
tients with recurrent seizures, and from (20%) to (30%)
in patients with controlled epilepsy25. Interictal depres-
sion (symptoms occur independently from the seizure oc-
currence) is the most frequently type of mood disor-
der25,26. The degree of depression in examinees with
hypothyroidism in our study is (24.2%), found mostly in
female population aged 36–55 yrs. According to litera-
ture, patients with hypothyroidism have a higher preva-
lence of depressive disorders than the general population
(15–25%), but the relationship with depression has not
been adequately studied yet27. Depression symptoms, as
psychomotor retardation, guilt, muscle pain, energy loss
and fatigue have overlapping features that can cause
misdiagnosis in the acute phase27,28. Mood disorders are
often unrecognized and untreated in patients with chro-
nic somatic illness, and appear in co-morbidity with alco-
holism and other substance abuses29. Such patients are
at higher risk for depression and life stresses than other
cultural groups. Thus, it is important that physicians
make referrals for psychiatric treatment. Doctors should
also be made aware that chronic illnesses, like epilepsy,
diabetes, asthma, chronic obstructive pulmonary disease
and hypothyroidism are more difficultly diagnosed and
treated in depressed patients. Depression caused by a
physical illness, or as a comorbidity of a chronic illness,
often aggravates the somatic illness itself, especially if
the condition causes pain, fatigue, or disruption of social
life. Depression also aggravates social functioning by
driving people into isolation1,4. Pharmacological and psy-
chotherapy treatments for depression are relatively well
developed and play an important role in reducing the ad-
verse impact of depression30.
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ISPITIVANJE U^ESTALOSTI DEPRESIVNOG POREME]AJA U BOLESNIKA KOJI
BOLUJU OD KRONI^NIH TJELESNIH BOLESTI
S A @ E T A K
Depresija je jedna od naj~e{}ih komplikacija u bolesnika koji boluju od kroni~nih somatskih bolesti. Depresija kao
komorbiditet kroni~nih tjelesnih bolesti ~esto ostaje neprepoznata i nelije~ena, {to pogor{ava tijek, lije~enje i prognozu
tjelesnih bolesti, te stanje oboljelog. Cilj ovog ispitivanja je ispitati prevalenciju i stupanj depresije u kroni~nih somat-
skih bolesnika koji boluju od dijabetesa, epilepsije, astme, kroni~ne opstruktivne plu}ne bolesti (KOPB) i hipotireoi-
dizma. Prisutnost simptoma i stupanj depresije ispitivani su u vremenu od 12 mjeseci, na bolesnicima koji se lije~e
ambulantno i redovito pohode kontrolne internisti~ke ili neurolo{ke preglede. Ispitivanje je provedeno Bekovim upitni-
kom za ispitivanje stupnja depresije. Uklju~eni su pacijenti u stanju remisije s obzirom na njihovu somatsku bolest.
Uzorak se sastojao od 2153 kroni~nih somatskih bolesnika u dobi od 18 do 80 godina. Statisti~ki nije obra|eno 228
(10.6%) ispunjenih upitnika ispitanika, jer (5.12%) nije valjano ispunilo upitnik, a (5.5%) ispitanika je ispalo zbog tehni-
~kih pogre{aka. Rezultati ispitivanja u 1925 kroni~nih somatskih bolesnika, potvr|uju depresiju u 542 (28.5%) ispita-
nika, dva puta ~e{}e u `ena 346 (64%) nego u mu{karaca 196 (36%). Zna~ajan broj ispitanika stariji je od 55 godina
(49%). Od ukupnog broja depresivnih bolesnika, blaga depresija utvr|ena je u 284 (52,4%), srednje te{ka depresija u
186 (34.3%) i te`ak oblik depresije u 72 (13.3%) kroni~nih somatskih bolesnika. Depresija je u ovom ispitivanju utvr|e-
na u (25.6%) bolesnika koji boluju od astme, (26.6%) oboljelih od KOPB-a. Statisti~ki zna~ajna razlika vezana uz spol u
navedene dvije bolesti nije utvr|ena. Depresija je utvr|ena i u (32.2%) ispitanika oboljelih od dijabetesa, (29.6%) ispita-
nika oboljelih od epilepsije, te u (24.2%) ispitanika oboljelih od hipotireoidizma. U posljednje tri skupine ispitanika
utvr|ena je i statisti~ki zna~ajna razlika po spolu (p<0.001).
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